Gynecological Oncology

Although the diagnosis of cancer is always disturbing, gynecologic cancers are particularly traumatic because they strike at the specialized biology of a woman. Treating the most common of these cancers -- ovarian, cervical and uterine, along with the less common types -- the gynecologic oncology program emphasizes early detection and aggressive treatment.

Treatment depends not only on factors including the type of tumor, the rate of growth, and the extent, or stage of the disease, but our physicians also consider the "entire" patient -- her age, her general health, as well as her outlook -- when developing a treatment plan. Treating the woman's individual needs is foremost.

Therapies available at the Nalitt Institute include surgery, radiation therapies (external beam and brachytherapy), chemotherapy, hormone therapy, or a combination of these options. Before beginning any form of therapy, the risks, anticipated benefits, and potential complications are discussed in detail with the patient.

Mitchell A. Maiman, M.D. Dr. Maiman is a board-certified gynecologic oncologist with numerous academic and clinical accomplishments as well as an extraordinary depth of experience in both the clinical and research arena. A former American Cancer Society Fellow, Dr. Maiman completed his residency in Obstetrics and Gynecology at the Albert Einstein College of Medicine and his fellowship training in Gynecologic Oncology at SUNY Downstate Medical Center, where he was Division Director and Associate Professor for many years. Today, Dr. Maiman is Chairman of Obstetrics and Gynecology at Staten Island University Hospital, as well as Director of Gynecologic Oncology. He is a Fellow of the American College of Obstetricians and Gynecologists, the American College of Surgeons, the Society of Gynecologic Oncologists, the International Gynecologic Cancer Society, the Association of Professors of Gynecology and Obstetrics, as well as the past president of the Brooklyn Gynecologic Society.